Interim Healthcare

The vendor opportunity at Interim Healthcare

Interim Healthcare operates 230 total locations, of which 226 are franchised and 4 are company-owned. The system contracted by 3.4% year-over-year, a signal that vendors should assess churn risk and net-new location potential carefully. The franchise charges a 5.5% royalty and signs franchisees to a 10-year initial term. Average unit volume is not disclosed in the most recent FDD.

For software vendors, the addressable market is the 226 franchised units. Because the franchisor mandates ORCA as the operational system, any competing or complementary solution must either integrate with ORCA or demonstrate a compelling reason to replace it at the HQ level. The absence of a disclosed designated-supplier program in Item 8 suggests that procurement rules may be less rigid than in systems with approved-vendor lists, but the ORCA mandate signals top-down control over core technology.

Who controls software purchasing

The 2025 FDD lists five executives at the corporate level. President & CEO Rexanne A. Domico and CFO Steve Gates are the most likely decision-makers for enterprise software investments. Jeff Chapuran, General Counsel, and Patricia M. McGillan, Associate General Counsel & Compliance Officer, will almost certainly review any agreement that touches data privacy, HIPAA compliance, or contractual terms. Steve Schildwachter, Chief Strategy, Marketing, & People Officer, may influence decisions around CRM, HR tech, or marketing platforms.

There are no multi-unit operators mapped in our corpus, which reinforces the HQ-centric buying model. Vendors should prepare for a single-threaded sales process targeting the C-suite in Florida, not a distributed field-sales motion.

Mandated and current tech stack

ORCA is the only technology system mandated in the 2025 FDD. The FDD does not disclose additional mandated or recommended software for POS, scheduling, billing, or clinical management beyond ORCA. This creates a clear integration requirement: any vendor selling into Interim Healthcare must demonstrate how their product works alongside ORCA or replaces a non-mandated function that ORCA does not cover.

Vendors offering complementary solutions—such as advanced analytics, caregiver recruiting, or compliance automation—should position themselves as ORCA-adjacent rather than ORCA-competitive. The lack of a named POS or CRM mandate also means there may be greenfield opportunities in those categories, subject to HQ approval.

Procurement, renewals, and timing

Item 8 of the FDD contains no extract on procurement rules, so the franchisor’s approach to supplier designation is not publicly detailed. This could mean an open procurement environment or simply that the franchisor does not disclose its purchasing policies in the FDD. Vendors should clarify this early in the sales process.

Renewal timing is clearer. Franchisees must provide 180 days’ notice of intent to renew and sign the then-current form of franchise agreement, along with a general release and a renewal fee. The 10-year term means that any given franchisee will face a renewal decision roughly once a decade. For vendors, the six-month notice window before renewal is a natural point to engage, as franchisees and the franchisor revisit operational commitments, including technology.

How to read the Interim Healthcare FDD

The 2025 Franchise Disclosure Document is the authoritative source for the facts cited here. It is filed with state franchise regulators and available in the embedded viewer below. Key sections for software vendors include Item 1 (executives), Item 11 (mandated systems), Item 8 (procurement restrictions), and Item 17 (renewal conditions). Reviewing these sections directly will help you validate the decision-maker list, confirm the ORCA mandate, and identify any undisclosed supplier requirements.

For a ranked target list of franchise systems matched to your software category, FranCloud can help you prioritize outreach based on unit counts, tech mandates, and HQ buying signals.